59 related articles for article (PubMed ID: 7872669)
1. Expression and alterations of CD66 antigen by interferon-gamma in human breast carcinoma cell lines.
Sedlak J; Duraj J; Hunakova L; Chorvath B
Anticancer Res; 1994; 14(6B):2473-6. PubMed ID: 7872669
[TBL] [Abstract][Full Text] [Related]
2. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
[TBL] [Abstract][Full Text] [Related]
3. Myeloid activation antigen CD66/67: immunochemical and immunocytometric characterization with the Vth workshop monoclonal antibodies.
Hunáková L; Duraj J; Holománová D; Sedlák J; Chorváth B
Neoplasma; 1994; 41(3):129-35. PubMed ID: 7935979
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human leukocyte interferon induces alterations in the antigen phenotype of human breast carcinoma cells.
Greiner JW
Anticancer Res; 1986; 6(4):653-8. PubMed ID: 3752945
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal, anti-domain and anti-peptide antibodies assign the molecular weight 160,000 granulocyte membrane antigen of the CD66 cluster to a mRNA species encoded by the biliary glycoprotein gene, a member of the carcinoembryonic antigen gene family.
Stoffel A; Neumaier M; Gaida FJ; Fenger U; Drzeniek Z; Haubeck HD; Wagener C
J Immunol; 1993 Jun; 150(11):4978-84. PubMed ID: 8496599
[TBL] [Abstract][Full Text] [Related]
6. Sialylated Lewis(x) and Lewis(a) determinants expression on human neoplastic cell lines: immunocytometric study with the 5th workshop monoclonal antibodies.
Sedlák J; Hunáková L; Sulíková M; Chorváth B
Neoplasma; 1995; 42(2):49-52. PubMed ID: 7542364
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and immunological phenotype alterations in human monoblastoid cell line U-937 induced by physiological (interferon-alpha, retinoic acid) and nonphysiological (phorbol ester) inducers.
Chorváth B; Sedlák J; Duraj J; Klobusická M; Plesková I; Augustinová M; Suliková M
Neoplasma; 1990; 37(3):317-31. PubMed ID: 2196473
[TBL] [Abstract][Full Text] [Related]
8. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
Gooch JL; Herrera RE; Yee D
Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
[TBL] [Abstract][Full Text] [Related]
9. Isoforms of leukocyte common antigen (CD45) on human neoplastic hematopoietic cell lines.
Sedlák J; Duraj J; Festin R; Plesková I; Poláková K; Chorváth B
Neoplasma; 1989; 36(6):643-50. PubMed ID: 2533326
[TBL] [Abstract][Full Text] [Related]
10. Modulation of protectin (CD59 antigen) cell surface expression on human neoplastic cell lines.
Sedlák J; Hunáková L; Duraj J; Grófová M; Chorváth B
Neoplasma; 1993; 40(6):337-40. PubMed ID: 7507222
[TBL] [Abstract][Full Text] [Related]
11. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.
Wright M; Grim J; Deshane J; Kim M; Strong TV; Siegal GP; Curiel DT
Gene Ther; 1997 Apr; 4(4):317-22. PubMed ID: 9176517
[TBL] [Abstract][Full Text] [Related]
12. Alterations of cell surface antigens induced by placental isoform of ferritin in human carcinoma cell lines.
Sedlak J; Reinerova M; Hunakova L; Ausch C; Chorvath B; Rosen H; Moroz C
Cancer Lett; 1995 Jul; 94(1):101-6. PubMed ID: 7542560
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class II antigen and costimulatory molecule expression on the surface of breast cancer cells.
Fan P; Wang S; Liu X; Zhen L; Wu Z
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):327-30. PubMed ID: 12408756
[TBL] [Abstract][Full Text] [Related]
14. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
16. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1.
Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of tumor antigens and their modulation by pleiotrophic modifiers enhance targeting of human monoclonal antibodies to pancreatic carcinoma.
Mukerjee S; McKnight ME; Nasoff M; Glassy MC
Hum Antibodies; 1999; 9(1):9-22. PubMed ID: 10331182
[TBL] [Abstract][Full Text] [Related]
18. Cell surface immunophenotype and gelatinase activity of the human breast carcinoma cell line (MCF-7/6) with functionally defective E-cadherin.
Hlavcák P; Sedláková O; Sedlák J; Hunáková L; Duraj J; Sulíková M; Bízik J; Castronovo V; Chorváth B
Neoplasma; 1999; 46(1):12-6. PubMed ID: 10355528
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the interferon-gamma-mediated regulation of tumor-associated antigens expressed by human gastric carcinoma cells.
Shimada S; Ogawa M; Schlom J; Greiner JW
In Vivo; 1993; 7(1):1-8. PubMed ID: 8504201
[TBL] [Abstract][Full Text] [Related]
20. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
Bacus SS; Gudkov AV; Zelnick CR; Chin D; Stern R; Stancovski I; Peles E; Ben-Baruch N; Farbstein H; Lupu R
Cancer Res; 1993 Nov; 53(21):5251-61. PubMed ID: 8106145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
